Alumis
Biotechnology, 5500 Flatiron Pkwy Unit 100, South San Francisco, California, 80301, United States, 11-50 Employees
Phone Number: 16*********
Who is ALUMIS
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated ...
Read More
-
Headquarters: 5500 Flatiron Pkwy Unit 100, South San Francisco, California, 80301, United States
-
Date Founded: 2021
-
Employees: 11-50
-
Revenue: $100 Million to $250 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 621112 |
Show More
Alumis Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Alumis
Answer: Alumis's headquarters are located at 5500 Flatiron Pkwy Unit 100, South San Francisco, California, 80301, United States
Answer: Alumis's phone number is 16*********
Answer: Alumis's official website is https://alumis.com
Answer: Alumis's revenue is $100 Million to $250 Million
Answer: Alumis's SIC: 2834
Answer: Alumis's NAICS: 621112
Answer: Alumis has 11-50 employees
Answer: Alumis is in Biotechnology
Answer: Alumis contact info: Phone number: 16********* Website: https://alumis.com
Answer: At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month